A Double-Blind, Placebo-Controlled, Two-Way Cross-Over in Healthy Volunteers, to Evaluate the Pharmacokinetics, Tolerability and Cardiac Safety of Prucalopride at Steady-State.
Phase of Trial: Phase I
Latest Information Update: 12 Jun 2015
At a glance
- Drugs Prucalopride (Primary)
- Indications Constipation
- Focus Adverse reactions
- Sponsors Shire-Movetis NV
- 02 Jun 2009 Long term follow-up results from this and another trial investigating the cardiovascularsafety of prucalopride in volunteers were presented at the Digestive Disease Week (DDW), according to Movetis media release.
- 28 Nov 2008 New trial record.